J591 humanized monoclonal antibody: Phase I

Interim results from 2 U.S. Phase I trials of J591 labeled with either

Read the full 138 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE